Lucy Yan

Lucy Yan, MD, Ph.D., is an experienced Executive Medical Director with a robust history in the biotechnology industry, specifically in Clinical Development, Translational Medicine, Clinical Pharmacology, and Gene Therapy. They have over 18 years of experience leading cross-functional program development and managing clinical trials across multiple therapeutic areas. Lucy's career includes roles at Pfizer, Amgen, Adverum Biotechnologies, and Rigel Pharmaceuticals, culminating in their current position as Vice President of Clinical Development at Nurix Therapeutics. They completed their Ph.D. in Pharmacogenomics and Clinical Pharmacology at the Mayo Clinic Graduate School of Biomedical Sciences and served as a post-doctoral fellow in Oncology and Cancer Biology at The Johns Hopkins University School of Medicine.